PTX 0.00% 4.3¢ prescient therapeutics limited

Ann: PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer, page-9

  1. 16,435 Posts.
    lightbulb Created with Sketch. 770
    17 out of 32 patients had stable disease (53%) in AML trial , compelling signs of efficacy. Price should be well over 10c imo based on this one trial alone. The other trials should value it another 10c.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
0.000(0.00%)
Mkt cap ! $34.62M
Open High Low Value Volume
4.3¢ 4.3¢ 4.2¢ $2.811K 65.48K

Buyers (Bids)

No. Vol. Price($)
1 95014 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 47513 1
View Market Depth
Last trade - 16.10pm 28/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.